Product Information
ALLERGY RELIEF 180 MG TABLET is a generic product labeled by Cardinal Health, priced at $0.2302 per EA under NDC 70000072601. Its NADAC has been published 42 times since Dec 17, 2025.
FDA first approved this application on Aug 19, 2016.
Strength
180 mg/1
Manufacturer
Cardinal HealthNDC
70000072601
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FEXOFENADINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204097FDA Approved
8/19/2016
On Market Since
8/19/2016
Pharmacological Classes
Price Statistics
The NADAC for ALLERGY RELIEF 180 MG TABLET has been published 42 times since Dec 17, 2025, and over the history we have for it it has declined 14.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2302 per EA |
|---|---|
| All-time high | $0.2703 (Jan 14, 2026) |
| All-time low | $0.2302 (Sep 23, 2026) |
| 52-week high | $0.2703 |
| 52-week low | $0.2302 |
| Median price | $0.2480 |
| Average price | $0.2498 |
| Largest weekly change | -4.9% (Feb 18, 2026) |
| Weeks tracked | 42 |
| Tracking since | Dec 17, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cardinal Health manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Fexofenadine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ALLERGY RELIEF 180 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ALLERGY RELIEF 180 MG TABLET, manufactured by Cardinal Health, is $0.2302 per EA (NDC 70000072601), effective Sep 30, 2026.
How has the price of ALLERGY RELIEF 180 MG TABLET changed over time?
Over the history we have for it, the NADAC for ALLERGY RELIEF 180 MG TABLET has declined 14.8%. It has been tracked across 42 weekly CMS publications since Dec 17, 2025.
What are the highest and lowest recorded NADAC prices for ALLERGY RELIEF 180 MG TABLET?
Since Dec 17, 2025, the NADAC for ALLERGY RELIEF 180 MG TABLET has ranged from a low of $0.2302 (Sep 23, 2026) to a high of $0.2703 (Jan 14, 2026), with a median of $0.2480 per EA.
Are there cheaper alternatives to ALLERGY RELIEF 180 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ALLERGY RELIEF 180 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ALLERGY RELIEF 180 MG TABLET?
ALLERGY RELIEF 180 MG TABLET (NDC 70000072601) is labeled by Cardinal Health, and CMS classifies it as a generic product.